August 27, 2016 9:31 AM ET

Healthcare Equipment and Supplies

Company Overview of electroCore LLC

Company Overview

electroCore LLC, a bioelectric medicine healthcare company, develops a non-invasive self-administered Vagus Nerve Stimulation (nVNS) therapy for the treatment of multiple conditions in neurology, psychiatry, respiratory, gastroenterology, and headaches. It focuses on primary headaches, such as migraine and cluster and trials in epilepsy, gastric motility disorders, depression, and anxiety. The company sells its products to patients through healthcare professionals in the United Kingdom, Germany, Italy, Australia, and Canada. electroCore LLC was founded in 2005 and is headquartered in Basking Ridge, New Jersey with offices in the Germany, the United Kingdom, Italy, Australia, and Canada.

150 Allen Road

Suite 201

Basking Ridge, NJ 07920

United States

Founded in 2005





Key Executives for electroCore LLC

Chief Executive Officer
Co-Founder, Chairman and Chief Science & Strategy Officer
Co-Founder and Chief Technology Officer
Co-Founder and Director
Chief Financial Officer
Compensation as of Fiscal Year 2016.

electroCore LLC Key Developments

electroCore LLC Announces Executive Changes

Frank Amato, previously Chief Operating Officer, has been appointed Chief Executive Officer of electroCore LLC. This change is part of a management-proposed development plan, unanimously approved by the company’s Board, designed to position the company for its next phase of growth. Mr. Amato, who joined electroCore in 2012 as COO, has extensive commercial experience in the pharmaceutical industry, most recently holding the position of US Vice President, Specialty Commercial Operations Group, at Merck. Founder and Board Member, JP Errico, who previously held the role of Chief Executive Officer, is transitioning to Chief Science and Strategy Officer, and will focus on leading the team that will spearhead the development of nVNS into other therapeutic areas in the CNS and beyond.

electroCore LLC Presents at JMP Securities 2016 Life Sciences Conference, Jun-22-2016 10:00 AM

electroCore LLC Presents at JMP Securities 2016 Life Sciences Conference, Jun-22-2016 10:00 AM. Venue: The St. Regis New York, 2 East 55th Street, New York, NY 10022, United States.

ElectroCore Appoints Desitin to Launch gammaCore for the Treatment of Primary Headache across Germany

ElectroCore’s non-invasive vagus nerve stimulation device, gammaCore, will be launched across Germany by Desitin for the treatment of migraine and cluster headache. The agreement with Desitin took effect on January 1, 2016. GammaCore is well known in Germany as many of the headache centres across the country took part in the successful clinical trial program.

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems, Inc. United States
20/20 Imaging LLC United States
21st Century Scientific, Inc. United States
21X Corporation United States

Recent Private Companies Transactions

Private Placement
June 29, 2016

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact electroCore LLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at